In the Boardroom
Refine Search
Pharmaceutical
Waypoint Capital, the business enterprise for investments associated with the Bertarelli family, has named Christopher Viehbacher as the managing partner of its US-based Gurnet Point Capital (GPC) fund. 24 June 2015
Pharmaceutical
American pharma company Pozen has appointed Mark Glickman as chief commercial officer, Eric Trachtenberg as deputy general counsel, and Jennifer Armstrong as executive vice president of human resources and administration. 22 June 2015
Pharmaceutical
Anglo-Swedish drug major AstraZeneca has appointed Pam Cheng as executive vice president of operations and IT. 16 June 2015
Pharmaceutical
Briggs Morrison, former vice president global medicines development and chief medical officer at AstraZeneca, is joining privately-held oncology company Syndax Pharmaceuticals as chief executive officer. 16 June 2015
Pharmaceutical
Canada-based pharma company Valeant has appointed Robert Rosiello as chief financial officer. 11 June 2015
Pharmaceutical
Privately-held biopharma company Turing Pharmaceuticals has appointed Eliseo Oreste Salinas as president of research and development. 2 June 2015
Pharmaceutical
Japanese drug major Eisai has appointed Ivor Macleod as senior vice president, chief financial officer and chief compliance officer of its US pharma subsidiary. 2 June 2015
Pharmaceutical
Ronald Martell has been appointed to the position of executive chairman of KaloBios Pharmaceuticals. 29 May 2015
Pharmaceutical
Paolo Paoletti has been appointed as executive chairman of multiple myeloma specialist Kesios Therapeutics. 29 May 2015
Pharmaceutical
Joseph Bedford appointed corporate vice president of global strategic marketing at Huntingdon/Harlan
Huntingdon Life Sciences and Harlan Laboratories have appointed Joseph Bedford as corporate vice president of global strategic marketing. 27 May 2015
Pharmaceutical
French drug major Sanofi has appointed Suresh Kumar as a new member of the executive committee and as executive vice president of external affairs. 26 May 2015
Pharmaceutical
Clinical-stage infection-focused biopharma company Nabriva Therapeutics has appointed Elyse Seltzer as chief medical officer. 22 May 2015
Pharmaceutical
French biopharma company Poxel has appointed Noah Beeman as executive vice president of business development and president of US operation to spearhead the company’s expanding presence in the USA. 21 May 2015
Pharmaceutical
US specialty pharma company CutisPharma has appointed Neal Muni as chief executive. 19 May 2015
Pharmaceutical
Antibody specialist Xencor has appointed Mark Lotz as vice president of regulatory affairs and Wayne Saville as vice president of clinical oncology. 13 May 2015
Pharmaceutical
Danish CNS specialist Lundbeck has appointed Kre Schultz as the new president and chief executive. 6 May 2015
Pharmaceutical
Australia’s CSL Limited today announced that Gordon Naylor will lead the company’s new global influenza vaccine business, which is planned for launch at the start of 2016. 23 April 2015
Pharmaceutical
Dutch privately-held life sciences company Cristal Therapeutics has appointed Jeroen Tonnar as new chief business officer responsible for business development, partnering and licensing activities. 21 April 2015
Pharmaceutical
Danish CNS specialist Lundbeck has entered into an exclusive worldwide license agreement with privately-held US biotech start-up Ovid Therapeutics for gaboxadol. 19 April 2015
Pharmaceutical
Alise Reicin has been appointed head of global clinical development in the biopharma business of Germany’s Merck KGaA. 17 April 2015
Pharmaceutical
UK-based NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announced the appointment of Michael Shih as chief executive (CEO) and to the board of directors, effective immediately. 16 December 2024
Pharmaceutical
US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief medical officer (CMO) and will become a member of Gilead’s senior leadership team. Dr Berger succeeds Dr Merdad Parsey. 13 December 2024
Pharmaceutical
AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while under investigation in China. 4 December 2024
Pharmaceutical
Bausch Health Bausch Health (NYSE/TSX: BHC) has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. 3 December 2024
Pharmaceutical
Germany’s Evotec has said its chief operating officer Craig Johnstone will leave the business at the end of the year. 29 November 2024
Pharmaceutical
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that Dr Thomas Schinecker, chief executive (CEO) of Swiss pharma giant Roche (ROG: SIX), will take up the post as president of the trade association effective January 1, 2025. 26 November 2024
Pharmaceutical
Specialist pre-clinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has announced the appointment of Lee Patterson as its new chief executive. 25 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Pharmaceutical
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Pharmaceutical
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze